DUBLIN--(BUSINESS WIRE)-- <\/p>\n
Research and Markets (http:\/\/www.researchandmarkets.com\/research\/t8mv4n\/global_psoriasis<\/a>) has announced the addition of the \"Global Psoriasis Drug Pipeline Capsule - 2012 Update\" report to their offering. <\/p>\n Fore Pharma's latest report 'Global Psoriasis Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Psoriasis market. It covers active Psoriasis pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery. <\/p>\n This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals. <\/p>\n The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report. <\/p>\n Key Topics Covered: <\/p>\n 1. Psoriasis - Disease Overview <\/p>\n 2. Psoriasis Pipeline Overview <\/p>\n 3. Psoriasis Phase 3 Clinical Trial Pipeline Insights <\/p>\n 4. Psoriasis Phase 2 Clinical Trial Pipeline Insights <\/p>\n<\/p>\n See the original post here: DUBLIN--(BUSINESS WIRE)-- Research and Markets (http:\/\/www.researchandmarkets.com\/research\/t8mv4n\/global_psoriasis<\/a>) has announced the addition of the \"Global Psoriasis Drug Pipeline Capsule - 2012 Update\" report to their offering. Continue reading
\nResearch and Markets: Global Psoriasis Drug Pipeline Capsule - 2012 Update<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"